UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 17, 2015 4:00 P.M.
Form:
F-1
CIK:
0001641640
Company Name:
Nabriva Therapeutics AG
File Number:
333-205073